CNDA Commissioner participates in drug information meetings

Jiao Hong, Commissioner of the National Drug Administration of China (CNDA), this week attended the 2018 China International Drug Information Meeting in Beijing and the DIA China 10th Annual Meeting, the China Food and Drug Administration announced today.

Jiao Hong pointed out that the newly-formed CNDA should resolutely implement the strategic deployment of the CPC Central Committee and the State Council of China, adhered to the people as the center and persist in deepening the reform of the review and approval system, and ensure that all the reform tasks are put in place on a time-bound basis.

Ms Jiao stressed that drug regulatory departments should accelerate regulatory innovation, guide industrial innovation and development, and meet people's demand for medication.

She added that the CNDA should further promote international exchanges and cooperation, promote the sharing and mutual recognition of international regulatory data, and ensure more safe, effective and high-quality drugs to enter the market more and faster.

Before the meeting, Ms Jiao also met with the foreign guests attending the meeting and the relevant personnel of the ICH Management Committee.

Relevant directors of international cooperation, Center for Drug Evaluation, China Center for Pharmaceutical International Exchange and Chinese Pharmaceutical Association of the former China Food and Drug Administration (CFDA) participated in the meeting.